Dermata Therapeutics, Inc. is a skincare company transitioning from prescription drug development to direct-to-consumer (DTC) and B2B skincare products. Its hero ingredient is Spongilla lacustris, a freshwater sponge processed into a powder called Bioneedle. The company completed a Phase 3 clinical trial (STAR-1) for XYNGARI, an acne treatment, and is now launching the 'Tome' skincare brand with cosmetic and OTC acne products expected in mid-2026.
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001493152-26-012992 | EDGAR | 96K words |
| 2025-03-17 | 2024-12-31 | 0001654954-25-002885 | EDGAR | 106K words |
| 2024-03-21 | 2023-12-31 | 0001654954-24-003501 | EDGAR | 88K words |
| 2023-02-21 | 2022-12-31 | 0001654954-23-001926 | EDGAR | 99K words |
| 2022-03-28 | 2021-12-31 | 0001654954-22-003869 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001493152-26-037127 | EDGAR | 24K words |
| 2025-11-14 | 2025-09-30 | 0001493152-25-023474 | EDGAR | 25K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023572 | EDGAR | 21K words |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010111 | EDGAR | 20K words |
| 2024-11-13 | 2024-09-30 | 0001654954-24-014274 | EDGAR | 20K words |
| 2024-08-07 | 2024-06-30 | 0001654954-24-010103 | EDGAR | 19K words |
| 2024-05-15 | 2024-03-31 | 0001654954-24-006398 | EDGAR | 17K words |
| 2023-11-09 | 2023-09-30 | 0001654954-23-014016 | EDGAR | 18K words |
| 2023-08-10 | 2023-06-30 | 0001654954-23-010487 | EDGAR | 18K words |
| 2023-05-11 | 2023-03-31 | 0001654954-23-006208 | EDGAR | 16K words |
| 2022-11-10 | 2022-09-30 | 0001654954-22-015035 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001654954-22-011375 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-17 | 0001493152-26-038647 | EDGAR | 1K words |
| 2026-08-11 | 0001493152-26-037124 | EDGAR | 2K words |
| 2026-08-05 | 0001493152-26-036109 | EDGAR | 1K words |
| 2026-03-26 | 0001493152-26-012991 | EDGAR | 2K words |
| 2026-02-25 | 0001493152-26-008037 | EDGAR | 1K words |
| 2026-02-03 | 0001493152-26-004905 | EDGAR | 1K words |
| 2026-01-27 | 0001493152-26-003715 | EDGAR | 1K words |
| 2025-12-29 | 0001493152-25-029364 | EDGAR | 1K words |
| 2025-11-18 | 0001493152-25-023942 | EDGAR | 1K words |
| 2025-11-14 | 0001493152-25-023419 | EDGAR | 2K words |
127 total filings indexed. 100 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001853816 |
| Ticker | DRMA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.dermatarx.com |
| Listed | 2021-08-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DRMA (~200 tokens, structured JSON with cryptographic provenance)